title: [Hepatitis following anistreplase-induced fibrinolysis in the acute phase of myocardial infarction].
authors.forename: S
authors.initials: S
authors.lastname: Dubettier
authors.forename: T
authors.initials: T
authors.lastname: Vial
authors.forename: B
authors.initials: B
authors.lastname: Falque
authors.forename: G
authors.initials: G
authors.lastname: Finet
authors.forename: M
authors.initials: M
authors.lastname: Lagable
authors.forename: H
authors.initials: H
authors.lastname: Milon
authors.forename: J C
authors.initials: JC
authors.lastname: Evreux
mesh_terms: D016255:Anistreplase / Q000009:adverse effects* / Q000627:therapeutic use; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy*
chemical_list: D016255:Anistreplase
vernacular_title: Hépatite après fibrinolyse par l'anistreplase à la phase aiguë d'un infarctus du myocarde.